Adhemar Longatto-Filho

26PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 11, 2026
Frizzled-9 Expression Is Associated With Aggressive Clinicopathological Features and Reduced Overall Survival in Invasive Breast Carcinoma.

Daniel Rodrigues de Bastos, Ricardo Cesar Cintra, Adhemar Longatto-Filho

|Feb 27, 2026
The Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review.

Ana Carla Franco Ubinha, Camila Musa Honorato, Marcelo Henrique Dos Santos

|Dec 11, 2025
Functional and Mechanistic Insights of 3-Hydroxybutyrate (3-OBA) in Bladder Cancer.

Ana Silva, Ana Mafalda Félix, Céline S Gonçalves

|Jul 09, 2025
Comparative performance of cobas 4800 HPV Test and Anyplex II HPV HR for high-risk human papillomavirus detection.

Luani R Godoy, Mariam El-Zein, Elizaveta Padalko

|Apr 17, 2025
Gastrin-releasing peptide receptor: a promising new biomarker to identify cervical precursor lesions and cancer.

Martina Lichtenfels, Rafaella Almeida Lima Nunes, Rossana Veronica Mendoza López

|Sep 11, 2024
High Levels of Superoxide Dismutase 2 Are Associated With Worse Prognosis in Patients With Breast Cancer.

Daniel Rodrigues de Bastos, Adhemar Longatto-Filho, Mércia Patrícia Ferreira Conceição

Pageof 5